BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 15, 2014
View Archived Issues
Phase II results for field-mixed avian influenza A/H7N9 vaccine with MF59 adjuvant
Read More
RAPID-PsA phase III results for certolizumab pegol in patients with active psoriasis
Read More
Stada Arzneimittel in-licenses teriparatide biosimilar
Read More
Identification of a novel druggable target for the development of new anxiolytics
Read More
Rigontec in first closing of Series A financing
Read More
Promising results presented for the novel EGFR tyrosine kinase inhibitor, AZD-9291
Read More
GAPVAC consortium advances a personalized cancer vaccine approach into the clinic for glioblastoma
Read More
In vitro inhibition of Middle East respiratory syndrome coronavirus with BanLec
Read More
Cutaneous tolerability and therapeutic benefits of LAS-41010
Read More
Phase I data for MPDL-3280A for the treatment of UBC and other malignancies
Read More
Researchers at Merck & Co. disclose new agents for Alzheimer's disease
Read More
A team of scientists at Amgen synthesizes novel protease inhibitors
Read More
Merck Sharp & Dohme designs new tyrosine-protein kinase inhibitors
Read More
Researchers at Roche present novel A-FABP inhibitors
Read More
Seragon Pharmaceuticals designs novel ER-alpha ligands for cancer and other disorders
Read More
GW Pharmaceuticals reports topline results from the phase IIa GWP-42003 trial
Read More
Aethlon Medical uses Hemopurifier blood filtration device in patient with Ebola virus infection
Read More
Raze Therapeutics formed to target mitochondrial one-carbon metabolism in cancer cells
Read More
Mochida and LG Life Sciences enter adalimumab biosimilar agreement
Read More
MRC Technology and Proximagen collaborate in inflammatory and autoimmune diseases
Read More
FDA grants olaratumab orphan drug status for soft tissue sarcoma
Read More
Resimmune receives orphan designation for cutaneous T-cell lymphoma in the U.S.
Read More
FDA grants priority review to rufinamide sNDA
Read More
FDA approves Quidel's Lyra Adenovirus Assay
Read More
Sorrento Therapeutics plans to reduce sample size in Cynviloq bioequivalence study
Read More
Zenith Epigenetics suspends development of ZEN-3365
Read More